Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News iShares Biotechnology ETF IBB

The fund seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on The NASDAQ Stock Market (NASDAQ). The fund seeks to track the investment results of the NASDAQ Biotechnology Index (the Underlying Index), which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as... see more

Recent & Breaking News (NDAQ:IBB)

Best biotech stocks to buy in 2023

Jocelyn Aspa June 1, 2023

Tarsus Added to NASDAQ Biotechnology Index

GlobeNewswire December 16, 2022

Aquestive Therapeutics Added to NASDAQ Biotechnology Index

GlobeNewswire December 17, 2021

Mustang Bio Added to the NASDAQ Biotechnology Index

GlobeNewswire December 16, 2021

Curis to be Added to the Nasdaq Biotechnology Index and the iShares Biotechnology ETF

PR Newswire December 15, 2021

The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug

Benzinga.com  April 12, 2019

The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug

Benzinga.com  April 11, 2019

The Daily Biotech Pulse: Amgen's Bone-Building Osteoporosis Drug Clears FDA Muster, PhaseBio Offering

Benzinga.com  April 10, 2019

The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing

Benzinga.com  April 9, 2019

The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership

Benzinga.com  April 5, 2019

The Daily Biotech Pulse: Recro Restructures, Biotechs Raise Proceeds In Droves, Silk Road, NGM Biopharma To Debut

Benzinga.com  April 4, 2019

The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings

Benzinga.com  April 3, 2019

Biotech Winners, Losers In Q1

Benzinga.com  April 1, 2019

Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates

Benzinga.com  March 29, 2019

The Daily Biotech Pulse: Safety Board Clears Eisai's Alzheimer's Study, Positive Trial Results For Galapagos-Gilead

Benzinga.com  March 29, 2019

The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO

Benzinga.com  March 28, 2019

Trump Administration Looks To Dump Affordable Care Act

Benzinga.com  March 26, 2019

The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs

Benzinga.com  March 26, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Benzinga.com  March 23, 2019

The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback

Benzinga.com  March 22, 2019